These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade. Robbins A; Arita I Int J Technol Assess Health Care; 1994; 10(1):39-46. PubMed ID: 8157459 [TBL] [Abstract][Full Text] [Related]
24. Exploring the transformative role of 3D printing in advancing medical education in Africa: a review. Olatunji G; Osaghae OW; Aderinto N Ann Med Surg (Lond); 2023 Oct; 85(10):4913-4919. PubMed ID: 37811062 [TBL] [Abstract][Full Text] [Related]
25. A call to action: securing an uninterrupted supply of Africa's medical products and technologies post COVID-19. Ejekam CS; Emeje M; Lukulay P; Uche CR; Odibeli O; Sanusi O; Anyakora C J Public Health Policy; 2023 Jun; 44(2):276-284. PubMed ID: 36997622 [TBL] [Abstract][Full Text] [Related]
27. A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic. Munshi R; Maurya M J Assoc Physicians India; 2023 Sep; 71(9):19-27. PubMed ID: 38700297 [TBL] [Abstract][Full Text] [Related]
28. Expanding the reach of vaccinology training in Africa: leveraging the success of the Annual African Vaccinology Course. Manga N; Amponsah-Dacosta E; Hussey G; Muloiwa R; Kagina BM Front Health Serv; 2023; 3():1119858. PubMed ID: 37727323 [TBL] [Abstract][Full Text] [Related]
29. Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction. Makenga G; Bonoli S; Montomoli E; Carrier T; Auerbach J Front Public Health; 2019; 7():56. PubMed ID: 30949465 [TBL] [Abstract][Full Text] [Related]
30. A Collaborative Initiative to Strengthen Sustainable Public Health Capacity for Polio Eradication and Routine Immunization Activities in the Eastern Mediterranean Region. Al Gunaid M; Lami F; Jarour N JMIR Public Health Surveill; 2019 Oct; 5(4):e14664. PubMed ID: 31663863 [TBL] [Abstract][Full Text] [Related]
31. Investing in health R&D: where we are, what limits us, and how to make progress in Africa. Simpkin V; Namubiru-Mwaura E; Clarke L; Mossialos E BMJ Glob Health; 2019; 4(2):e001047. PubMed ID: 30899571 [TBL] [Abstract][Full Text] [Related]
32. Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries. Mukherjee S; Kalra K; Phelan AL PLOS Glob Public Health; 2023; 3(6):e0002098. PubMed ID: 37384623 [TBL] [Abstract][Full Text] [Related]
33. Impact of COVID-19 on the neglected tropical diseases: a scoping review. Butala CB; Cave RNR; Fyfe J; Coleman PG; Yang GJ; Welburn SC Infect Dis Poverty; 2024 Jul; 13(1):55. PubMed ID: 39075616 [TBL] [Abstract][Full Text] [Related]
34. Developing vaccinology expertise for Africa: six years and counting. Wiysonge CS; Waggie Z; Mahomed H; Hawkridge A; Hatherill M; Hanekom WA; Hussey GD Vaccine; 2011 Aug; 29(35):5821-3. PubMed ID: 21718743 [TBL] [Abstract][Full Text] [Related]
35. Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives. Cortes Mde L; Cardoso D; Fitzgerald J; DiFabio JL Biologicals; 2012 Jan; 40(1):3-14. PubMed ID: 22033155 [TBL] [Abstract][Full Text] [Related]
36. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Breman JG; Alilio MS; Mills A Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814 [TBL] [Abstract][Full Text] [Related]
37. Polypharmacy Exposure, Aging Populations, and COVID-19: Considerations for Healthcare Providers and Public Health Practitioners in Africa. Nwanaji-Enwerem JC; Boyer EW; Olufadeji A Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639561 [TBL] [Abstract][Full Text] [Related]
38. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. Saied AA; Metwally AA; Dhawan M; Choudhary OP; Aiash H EMBO Mol Med; 2022 Aug; 14(8):e16287. PubMed ID: 35758210 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 as a catalyst for vaccine manufacturing: A South African experience. Moore PL; Gray G Cell Host Microbe; 2023 Jun; 31(6):839-842. PubMed ID: 37321166 [TBL] [Abstract][Full Text] [Related]